# Aurobindo Pharma Limited – FDA Inspection, Sep 5, 2025

Source: https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/bad39678-8eb7-42c7-b820-7b3bab50ca4f
Source feed: FDA_Inspections

> FDA inspection 1286862 of Aurobindo Pharma Limited, September 05, 2025. Classification: Official Action Indicated (OAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1286862
- Company Name: Aurobindo Pharma Limited
- Inspection Date: 2025-09-05
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1241780 - 2023-03-09
- FDA Inspection 1118385 - 2020-02-21
- [FDA Inspection 1046218 - 2018-03-16](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-limited/d4cc3587-20be-4443-8712-6e49c304278b)
- FDA Inspection 847151 - 2013-08-16
- FDA Inspection 793023 - 2012-06-26

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/claudia-m-perez-kasmarski/ee989ba2-eb7a-47ae-8be5-7a28f748343b)
- [Eileen A. Liu](https://www.keypedia.com/people/eileen-a-liu/fa051db4-1242-4181-9af9-5b3cd2de5689)
- [Issuing Officer](https://www.keypedia.com/people/joseph-a-piechocki/1977a57b-4976-4b01-b8da-66a84b26e803)

Company: https://www.keypedia.com/companies/aurobindo-pharma-limited/9bedb5d4-0483-4173-bc76-1c5737a28fc1

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
